Search

TransMedics Group Inc

Закрыт

СекторЗдравоохранение

72.14 -1.52

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

72

Макс.

74.67

Ключевые показатели

By Trading Economics

Доход

7.4M

15M

Продажи

16M

190M

P/E

Средняя по отрасли

18.359

49.241

Прибыль на акцию

0.44

Рентабельность продаж

7.729

Сотрудники

898

EBITDA

9.4M

37M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+30.36% upside

Дивиденды

By Acuity

Следующий отчет о доходах

28 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-336M

2.5B

Предыдущая цена открытия

73.66

Предыдущая цена закрытия

72.14

TransMedics Group Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

20 окт. 2026 г., 20:01 UTC

News

TransMedics Group Inc is positioned to benefit from the Trump administration's proposed kidney care plan aimed at enhancing competition and innovation in kidney treatment.

16 окт. 2026 г., 20:02 UTC

Transmedics Group Inc shares are declining, reversing a trend of higher daily closes that persisted since Thursday's close.

15 окт. 2026 г., 19:46 UTC

Social Media

Stifel projects Transmedics Group Inc. will report third-quarter revenue between $185 million and $190 million, exceeding the Street's estimate of $178 million.

14 окт. 2026 г., 20:07 UTC

Transmedics Group Inc shares fell sharply, closing significantly lower compared to Tuesday's close and reaching a low around midday.

13 окт. 2026 г., 20:02 UTC

News
Social Media

Canaccord Genuity maintains Buy rating on TransMedics Group Inc while lowering price target to $94.00, reflecting ongoing confidence in the company's prospects.

9 окт. 2026 г., 20:06 UTC

Transmedics Group Inc shares are declining, unable to sustain an early spike, and are currently positioned significantly below their 20-day moving average.

8 окт. 2026 г., 20:07 UTC

Transmedics Group Inc shares declined sharply on Thursday, finishing notably lower and remaining substantially below their 20-day moving average.

7 окт. 2026 г., 19:50 UTC

Social Media
News

TransMedics Group Inc. advanced after Barclays initiated coverage with an Overweight rating and a $120 price target, despite earlier pulling back from a session high.

5 окт. 2026 г., 20:06 UTC

News

Transmedics Group Inc shares rose following Piper Sandler's initiation of coverage with an "Overweight" rating and a $100 price target.

2 окт. 2026 г., 20:07 UTC

Transmedics Group Inc is gaining amid a broader market rally, driven by falling U.S. Treasury yields and improved investor sentiment since Thursday's close.

1 окт. 2026 г., 20:02 UTC

Transmedics Group Inc shares fell sharply, reversing a recent trend of higher daily closes amid a shift in the asset's performance.

30 сент. 2026 г., 19:15 UTC

Transmedics Group Inc shares fell after an early rise, currently trading below the 20-day moving average and near the lower end of its one-month range.

29 сент. 2026 г., 19:45 UTC

Transmedics Group Inc is trading higher, rebounding from an early dip, although it remains below its 20-day moving average and near the lower end of its one-month range.

25 сент. 2026 г., 20:07 UTC

Social Media

Transmedics Group Inc. shares rose following Canada's first Organ Care System heart transplant, expected to boost donor heart availability by 40%.

24 сент. 2026 г., 20:07 UTC

Transmedics Group Inc shares fell sharply, continuing a downward trend from Wednesday and finishing significantly below its 20-day moving average.

23 сент. 2026 г., 20:07 UTC

News

Transmedics Group Inc shares fell amid a broader market decline, despite reaffirming 2026 revenue guidance of $737 million to $757 million.

22 сент. 2026 г., 19:15 UTC

News

Transmedics Group Inc. appointed Fernando Araujo as CFO and reaffirmed 2026 revenue guidance of $737M to $757M, with shares trading higher.

21 сент. 2026 г., 20:06 UTC

Social Media

Transmedics Group Inc is trading higher following validation from a federal agency and a $7.27M contract for liver recovery services from Veterans Integrated Service Network 4.

18 сент. 2026 г., 20:06 UTC

Transmedics Group Inc shares fell, closing below Thursday's level after fluctuating throughout the day, marking three consecutive sessions of lower closes.

17 сент. 2026 г., 20:07 UTC

Transmedics Group Inc shares fell Thursday, declining from Wednesday's close despite a brief earlier rebound, amid overall lower market performance.

16 сент. 2026 г., 20:10 UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

15 сент. 2026 г., 20:07 UTC

Social Media

TransMedics Group shares are rising following an insider purchase by Director David Weill at $81.63, amid positive social media discussions about the company.

14 сент. 2026 г., 20:03 UTC

TransMedics Group Inc shares are gaining during Monday's session, despite earlier pullbacks. Broader market volatility is influenced by rising crude oil prices and inflation concerns.

11 сент. 2026 г., 20:02 UTC

News
Event
Social Media

TransMedics Group Inc shares are lower following the announcement of a CFO transition. The company reaffirmed its 2026 revenue guidance of $737 million to $757 million.

10 сент. 2026 г., 20:06 UTC

Transmedics Group Inc shares are lower amid broader market pressure, reflecting ongoing concerns over rising Treasury yields and inflation. No specific company news was identified.

9 сент. 2026 г., 20:07 UTC

Social Media

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8 сент. 2026 г., 19:56 UTC

News
Social Media

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4 сент. 2026 г., 20:07 UTC

News

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2 сент. 2026 г., 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1 сент. 2026 г., 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.

Сравнение c конкурентами

Изменение цены

TransMedics Group Inc Прогноз

Целевая цена

By TipRanks

30.36% рост

Прогноз на 12 месяцев

Средняя 97.444 USD  30.36%

Максимум 122 USD

Минимум 65 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для TransMedics Group Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

11 ratings

7

Покупка

4

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat